The influence of Gankang H on the level of bilirubin in chronic hepatitis B patients
10.3760/cma.j.issn.1673-4246.2011.11.006
- VernacularTitle:肝康Ⅱ号对慢性乙型肝炎患者胆红素水平的影响
- Author:
Qizheng LIU
;
Xingrong XIE
;
Fang LI
;
Jinke LI
;
Yunjing LI
;
Huabing TAN
- Publication Type:Journal Article
- Keywords:
Gankang Ⅱ;
Chronic hepatitis B;
Hyperbilirubinemia;
Effect
- From:
International Journal of Traditional Chinese Medicine
2011;33(11):979-981
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo observe the effect of Gankang Ⅱ in reducing bilirubin level of patients with chronic hepatitis B,and discuss the mechanism.Methods124 cases hyperbilirubinemia patients with chronic hepatitis B were randomly divided into Gankang Ⅱ treatment group (the treatment group for short),and Yinzhihuang particles treatment group (the control group for short),with 62 eases in each group.The cure rate,recover rate of the treatment group and control group were observed,together with the changes of ALT,AST,GGT,and TBiL.Results①The cure rate was 80.6％,the recover rate was 19.4％ in the treatment group; the cure rate of was 62.9％ and the recover rate was 37.1％ in the control group; the cure rate of the treatment group was obviously higher than the control group.② There was no significant difference between the treatment group and the control group on TBiL,ALT,AST,and GGT before the treatment (P＞0.05).while after treated,TBiL (20.75±3.77) μmol/L,ALT (52.53± 12.23) U/L,AST (51.75 ±9.93) μmol/L,GGT (48.75 ±16.68) U/L of the treatment group were obviously lower than the TBiL(26.68 ±4.99)μmol/L,ALT(79.68± 1 1.92)U/L,AST (60.12 ± 8.12) μmol/L,GGT (58.97±15.47)U/L of control group.There was significant difference(P＜0.05～0.01).ConclusionThe effect of Gankang Ⅱ in reducing the bilirubin level of patients with chronic hepatitis B was sound.
